AAN 2019
Read the full Report (pdf)
American Academy of Neurology
4–10 May 2019, Philadelphia, USA
Featured articles
Interview with Prof. Natalia Rost
CONTENTS
Online First
Alzheimer's Disease and other Dementias
Amyloid PET in cognitively impaired patients
Tight blood pressure control lowers risk of mild cognitive impairment
Two experimental antibodies reduce amyloid levels
How to implement brain-healthy behaviour in clinical practice
Epilepsy
Cannabidiol effective in children with Dravet syndrome
Possible role of brivaracetam in controlling acute seizures
Headache and Migraine
Long-term efficacy and safety of erenumab
Eptinezumab reduces mean monthly migraine days
Fremanezumab efficacy and safety maintained over 1 year
Lasmiditan: rapid onset of efficacy in acute migraine
Efficacy, tolerability, and safety of ubrogepant confirmed
Galcanezumab reduces cluster headache frequency
Non-invasive vagus nerve stimulation for cluster headache
Multiple Sclerosis and NMOSD
Three very promising new treatments of NMOSD
Immune tolerance by peptide-loaded tolerogenic dendritic cells
New compounds for MS treatment
Sequencing of high-efficacy disease-modifying treatments in MS
